ProfileGDS5678 / 1428161_a_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 112.578899
GSM967853U87-EV human glioblastoma xenograft - Control 212.747299
GSM967854U87-EV human glioblastoma xenograft - Control 312.840299
GSM967855U87-EV human glioblastoma xenograft - Control 413.037299
GSM967856U87-EV human glioblastoma xenograft - Control 512.755899
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 112.350299
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 212.239899
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 312.641699
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 412.724799
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 112.861199
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 212.533699
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 312.819399
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 412.648999
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 512.648499